Over 1 million 600 thousand Americans novel coronavirus pneumonia lose normal olfactory

Over 1 million 600 thousand Americans novel coronavirus pneumonia lose normal olfactory The novel coronavirus pneumonia is characterized by loss of smell and disorder. Patients can not smell or smell, which can cause a disgusting effect on their quality of life. Recently, JAMA Journal of Otolaryngology Head and neck surgery reported that 1.6 million people in the United States have been troubled by this symptom for a long time. The report indicates that novel coronavirus pneumonia is the most common symptom in some 52.7% of the patients with new crown pneumonia. The number of cases with olfactory dysfunction…

Low mortality of Omicron? The Yearbook of oncology says that the mortality rate of breakthrough infection in cancer patients is 13%

Low mortality of Omicron? The Yearbook of oncology says that the mortality rate of breakthrough infection in cancer patients is 13% Recently, European and American countries often use “Omicron mortality is very low” as self comfort. Is it feasible? In December 24th, the oncology Yearbook warned that cancer patients who are high-risk groups, even if they are vaccinated completely, will have a mortality rate of 13% after COVID-19 breakthrough infection. Novel coronavirus pneumonia is the first clinical study in the world to get a breakthrough infection in patients with completely vaccinated cancer. The new alliance is led by…

Should the new crown promote family self inspection? Experts say self inspection makes disease control know nothing.

Should the new crown promote family self inspection? Experts say self inspection makes disease control know nothing.Nucleic acid detection sites in American medical institutions have been difficult to meet the growing detection needs. In order to speed up the detection efficiency, the U.S. government is actively promoting the family antigen detection kit, so that users can easily and quickly detect themselves. However, who will track the self inspection results?

Pfizer said a third dose of vaccine could prevent Omicron infection

On December 7, the African Institute of health released information that the neutralizing antibody titer against Omicron variant in two doses of Pfizer vaccine was 41 times lower than that of the original strain, which attracted global attention. Pfizer released similar data the next day, saying that the antibody titer decreased 25 times, and two doses of vaccine may not be enough to prevent Omicron infection.

Interview with the first R & D team of new crown antibody combination therapy in China! How effective is the response to Omicron?

The worldwide COVID-19 pandemic has, to a certain extent, made the world more aware of and understanding of China, and the world people have seen the achievements and the national spirit reflected in China's struggle against COVID-19. Moreover, COVID-19 has also accelerated the R & D Progress of China's pharmaceutical enterprises and promoted the development of the national pharmaceutical industry. This exclusive interview mainly visited the R & D team of China's first new crown antibody combination therapy.